Randomized comparison of venlafaxine with escitalopram for selecting the antidepressant indicating better responses to serotonin-noradrenaline reuptake inhibitor(SNRI) or selective serotonin reuptake inhibitor(SSRI) for major depressive disorder(MDD)
Not Applicable
Recruiting
- Conditions
- Major Depressive Disorder
- Registration Number
- JPRN-UMIN000022267
- Lead Sponsor
- Department of psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
A) The patients who have any history of neurological diseases or other physical diseases. B) The patients who have comorbidities with other disorders, bipolar disorder, personality disorders, or mental retardation. C) The patients who have previous history of substance-related disorders, such as drug dependence or alcohol dependence. D) The patients who had previously treated with venlafaxine or escitalopram. E) The patients who their physicians consider not suited.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 17-item Hamilton Rating Scale for Depression: HAMD17
- Secondary Outcome Measures
Name Time Method Clinical Global Improvement-Severity (CGI-S) Quick Inventory of Depressive Symptomatology (QIDS-J) Udvalg for Kliniske Undersogelser (UKU) Cognitive function test (COGNITRAX)